We created this page for medical staff.
- *Read carefully the package insert before use.
Heart-type fatty acid-binding protein (H-FABP) is a soluble protein that is abundant in cardiomyocytes and has a molecular weight of approximately 15 k Da. It is involved in intracellular transport of free fatty acids, and plays an important role in supplying energy to cardiomyocytes. Because it is released into the blood when cardiomyocytes are injured by myocardial ischemia, it is known as an important marker for the early diagnosis of acute myocardial infarction (AMI).
Specification of Rapidchip H-FABP
|Drug Classification||In Vitro Diagnostics|
|Certification No. in Japan||226ADAMX00211000|
|Package||Test device 20 pcs. Accessory: CAL 1 pc.|
|Samples||Plasma or whole blood(EDTA-2Na・EDTA-2K, heparinized)|
|Measurement Time||10 min|
|Measurement Range||2.0-160 ng/mL|
|Reference standard range||≤ 6.2 ng/mL1)2)|
|Detection Method||Reflected light intensity as measured by dedicated instrument Manufacturer|
1) Tanaka T. et al.: J Med Pharm Sci, 37, 1367, 1997. Japanese.
2) Wada K. et al. (author and editor): Laboratory test guide 2013–2014, 160, Bunkodo, 2013. Japanese.
|Rapidchip H-FABP Control*||1 × 2conc. × 0.5mL(lyophilized)||2-10℃|
- *Not an in vitro diagnostic product in Japan.
"Rapidpia" and all related logos are trademarks or registered trademarks of SEKISUI MEDICAL CO., LTD. in Japan and/or other countries.
"Rapidchip" is trademark or registered trademark of SEKISUI MEDICAL CO., LTD. in Japan and/or other countries.
We prepared this page for medical staff (doctors, dentists, pharmacists, clinical laboratory technicians, nurses, etc.) in Japan to ensure the correct use of our products. You should be aware that the information provided is not intended for overseas medical staff and the general public.